Crucell and Pepscan partnered to develop vaccines for undisclosed infectious diseases using Pepscan's Chemical Linkage of Peptides onto Scaffolds (CLIPS) technology

Pepscan Therapeutics B.V.

the Netherlands / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Crucell N.V.

the Netherlands / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced